These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 23416123

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Genotypic profiles of Leishmania (Viannia) braziliensis strains from cutaneous leishmaniasis patients and their relationship with the response to meglumine antimoniate treatment: a pilot study.
    Gagini T, de Oliveira Schubach A, de Fatima Madeira M, Maria Valete-Rosalino C, Fernandes Pimentel MI, da Silva Pacheco R.
    Parasite; 2017; 24():34. PubMed ID: 28959938
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Assessing aquaglyceroporin gene status and expression profile in antimony-susceptible and -resistant clinical isolates of Leishmania donovani from India.
    Mandal S, Maharjan M, Singh S, Chatterjee M, Madhubala R.
    J Antimicrob Chemother; 2010 Mar; 65(3):496-507. PubMed ID: 20067981
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. In Vitro Sensitivity of Cutaneous Leishmania Promastigote Isolates Circulating in French Guiana to a Set of Drugs.
    Ginouvès M, Simon S, Nacher M, Demar M, Carme B, Couppié P, Prévot G.
    Am J Trop Med Hyg; 2017 May; 96(5):1143-1150. PubMed ID: 28167598
    [Abstract] [Full Text] [Related]

  • 10. Drug resistance in leishmaniasis: its implication in systemic chemotherapy of cutaneous and mucocutaneous disease.
    Grogl M, Thomason TN, Franke ED.
    Am J Trop Med Hyg; 1992 Jul; 47(1):117-26. PubMed ID: 1322070
    [Abstract] [Full Text] [Related]

  • 11. Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis.
    Arevalo J, Ramirez L, Adaui V, Zimic M, Tulliano G, Miranda-Verástegui C, Lazo M, Loayza-Muro R, De Doncker S, Maurer A, Chappuis F, Dujardin JC, Llanos-Cuentas A.
    J Infect Dis; 2007 Jun 15; 195(12):1846-51. PubMed ID: 17492601
    [Abstract] [Full Text] [Related]

  • 12. Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V.) guyanensis in Brazil: therapeutic response to meglumine antimoniate.
    Romero GA, Guerra MV, Paes MG, Macêdo VO.
    Am J Trop Med Hyg; 2001 Nov 15; 65(5):456-65. PubMed ID: 11716098
    [Abstract] [Full Text] [Related]

  • 13. Mucosal leishmaniasis: A forgotten disease, description and identification of species in 50 Colombian cases.
    Muvdi-Arenas S, Ovalle-Bracho C.
    Biomedica; 2019 Aug 01; 39(Supl. 2):58-65. PubMed ID: 31529834
    [Abstract] [Full Text] [Related]

  • 14. Molecular identification of the parasites causing cutaneous leishmaniasis on the Caribbean coast of Colombia.
    Martínez LP, Rebollo JA, Luna AL, Cochero S, Bejarano EE.
    Parasitol Res; 2010 Feb 01; 106(3):647-52. PubMed ID: 20084397
    [Abstract] [Full Text] [Related]

  • 15. Resistance to antimony and treatment failure in human Leishmania (Viannia) infection.
    Rojas R, Valderrama L, Valderrama M, Varona MX, Ouellette M, Saravia NG.
    J Infect Dis; 2006 May 15; 193(10):1375-83. PubMed ID: 16619185
    [Abstract] [Full Text] [Related]

  • 16. Identification of antimony resistance markers in Leishmania tropica field isolates through a cDNA-AFLP approach.
    Kazemi-Rad E, Mohebali M, Khadem-Erfan MB, Saffari M, Raoofian R, Hajjaran H, Hadighi R, Khamesipour A, Rezaie S, Abedkhojasteh H, Heidari M.
    Exp Parasitol; 2013 Oct 15; 135(2):344-9. PubMed ID: 23928349
    [Abstract] [Full Text] [Related]

  • 17. Multilocus genotyping reveals a polyphyletic pattern among naturally antimony-resistant Leishmania braziliensis isolates from Peru.
    Adaui V, Maes I, Huyse T, Van den Broeck F, Talledo M, Kuhls K, De Doncker S, Maes L, Llanos-Cuentas A, Schönian G, Arevalo J, Dujardin JC.
    Infect Genet Evol; 2011 Dec 15; 11(8):1873-80. PubMed ID: 21871584
    [Abstract] [Full Text] [Related]

  • 18. First case of cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis in Suriname.
    Hu RV, Kent AD, Adams ER, van der Veer C, Sabajo LO, Mans DR, de Vries HJ, Schallig HD, Lai A Fat RF.
    Am J Trop Med Hyg; 2012 May 15; 86(5):825-7. PubMed ID: 22556081
    [Abstract] [Full Text] [Related]

  • 19. Expression analysis of activated protein kinase C gene (LACK1) in antimony sensitive and resistant Leishmania tropica clinical isolates using real-time RT-PCR.
    Hajjaran H, Kazemi-Rad E, Mohebali M, Oshaghi MA, Khadem-Erfan MB, Hajaliloo E, Reisi Nafchi H, Raoofian R.
    Int J Dermatol; 2016 Sep 15; 55(9):1020-6. PubMed ID: 27336481
    [Abstract] [Full Text] [Related]

  • 20. Responses of Leishmania (Viannia) braziliensis cutaneous infection to N-methylglucamine antimoniate in the rhesus monkey (Macaca mulatta) model.
    Teva A, Porrozzi R, Oliveira-Neto MP, Grimaldi GJ.
    J Parasitol; 2005 Aug 15; 91(4):976-8. PubMed ID: 17089782
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.